Dermatofibrosarcoma protuberans, version 1.2014

Christopher K. Bichakjian; Thomas Olencki; Murad Alam; James S. Andersen; Daniel Berg; Glen M. Bowen; Richard T. Cheney; Gregory A. Daniels; L. Frank Glass; Roy C. Grekin; Kenneth Grossman; Alan L. Ho; Karl D. Lewis; Daniel D. Lydiatt; William H. Morrison; Kishwer S. Nehal; Kelly C. Nelson; Paul Nghiem; Clifford S. Perlis; Ashok R. Shaha; Wade L. Thorstad; Malika Tuli; Marshall M. Urist; Timothy S. Wang; Andrew E. Werchniak; Sandra L. Wong; John A. Zic; Nicole McMillian; Karin Hoffman; Maria Ho

doi:10.6004/jnccn.2014.0081

Dermatofibrosarcoma protuberans, version 1.2014

Christopher K. Bichakjian, Thomas Olencki, Murad Alam, James S. Andersen, Daniel Berg, Glen M. Bowen, Richard T. Cheney, Gregory A. Daniels, L. Frank Glass, Roy C. Grekin, Kenneth Grossman, Alan L. Ho, Karl D. Lewis, Daniel D. Lydiatt, William H. Morrison, Kishwer S. Nehal, Kelly C. Nelson, Paul Nghiem, Clifford S. Perlis, Ashok R. ShahaWade L. Thorstad, Malika Tuli, Marshall M. Urist, Timothy S. Wang, Andrew E. Werchniak, Sandra L. Wong, John A. Zic, Nicole McMillian, Karin Hoffman, Maria Ho

Research output: Contribution to journal › Review article › peer-review

32 Scopus citations

Abstract

Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue tumor characterized by a relatively high risk of local recurrence and low risk of metastasis. The NCCN Guidelines for DFSP provide multidisciplinary recommendations on the management of patients with this rare disease. These NCCN Guidelines Insights highlight the addition of the Principles of Pathology section, which provides recommendations on the pathologic assessment of DFSP. Because DFSP can mimic other lesions, immunohistochemical studies are often required to establish diagnosis. Cytogenetic testing for the characteristic translocation t(17;22)(q22;q13) can also be valuable in the differential diagnosis of DFSP with other histologically similar tumors.

Original language	English
Pages (from-to)	863-868
Number of pages	6
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	12
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2014.0081
State	Published - Jun 1 2014

Access to Document

10.6004/jnccn.2014.0081

Cite this

Bichakjian, C. K., Olencki, T., Alam, M., Andersen, J. S., Berg, D., Bowen, G. M., Cheney, R. T., Daniels, G. A., Glass, L. F., Grekin, R. C., Grossman, K., Ho, A. L., Lewis, K. D., Lydiatt, D. D., Morrison, W. H., Nehal, K. S., Nelson, K. C., Nghiem, P., Perlis, C. S., ... Ho, M. (2014). Dermatofibrosarcoma protuberans, version 1.2014. JNCCN Journal of the National Comprehensive Cancer Network, 12(6), 863-868. https://doi.org/10.6004/jnccn.2014.0081

@article{cec2c4072a164313bdb65be3eda4f348,

title = "Dermatofibrosarcoma protuberans, version 1.2014",

abstract = "Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue tumor characterized by a relatively high risk of local recurrence and low risk of metastasis. The NCCN Guidelines for DFSP provide multidisciplinary recommendations on the management of patients with this rare disease. These NCCN Guidelines Insights highlight the addition of the Principles of Pathology section, which provides recommendations on the pathologic assessment of DFSP. Because DFSP can mimic other lesions, immunohistochemical studies are often required to establish diagnosis. Cytogenetic testing for the characteristic translocation t(17;22)(q22;q13) can also be valuable in the differential diagnosis of DFSP with other histologically similar tumors.",

author = "Bichakjian, {Christopher K.} and Thomas Olencki and Murad Alam and Andersen, {James S.} and Daniel Berg and Bowen, {Glen M.} and Cheney, {Richard T.} and Daniels, {Gregory A.} and Glass, {L. Frank} and Grekin, {Roy C.} and Kenneth Grossman and Ho, {Alan L.} and Lewis, {Karl D.} and Lydiatt, {Daniel D.} and Morrison, {William H.} and Nehal, {Kishwer S.} and Nelson, {Kelly C.} and Paul Nghiem and Perlis, {Clifford S.} and Shaha, {Ashok R.} and Thorstad, {Wade L.} and Malika Tuli and Urist, {Marshall M.} and Wang, {Timothy S.} and Werchniak, {Andrew E.} and Wong, {Sandra L.} and Zic, {John A.} and Nicole McMillian and Karin Hoffman and Maria Ho",

year = "2014",

month = jun,

day = "1",

doi = "10.6004/jnccn.2014.0081",

language = "English",

volume = "12",

pages = "863--868",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "6",

}

Bichakjian, CK, Olencki, T, Alam, M, Andersen, JS, Berg, D, Bowen, GM, Cheney, RT, Daniels, GA, Glass, LF, Grekin, RC, Grossman, K, Ho, AL, Lewis, KD, Lydiatt, DD, Morrison, WH, Nehal, KS, Nelson, KC, Nghiem, P, Perlis, CS, Shaha, AR, Thorstad, WL, Tuli, M, Urist, MM, Wang, TS, Werchniak, AE, Wong, SL, Zic, JA, McMillian, N, Hoffman, K & Ho, M 2014, 'Dermatofibrosarcoma protuberans, version 1.2014', JNCCN Journal of the National Comprehensive Cancer Network, vol. 12, no. 6, pp. 863-868. https://doi.org/10.6004/jnccn.2014.0081

TY - JOUR

T1 - Dermatofibrosarcoma protuberans, version 1.2014

AU - Bichakjian, Christopher K.

AU - Olencki, Thomas

AU - Alam, Murad

AU - Andersen, James S.

AU - Berg, Daniel

AU - Bowen, Glen M.

AU - Cheney, Richard T.

AU - Daniels, Gregory A.

AU - Glass, L. Frank

AU - Grekin, Roy C.

AU - Grossman, Kenneth

AU - Ho, Alan L.

AU - Lewis, Karl D.

AU - Lydiatt, Daniel D.

AU - Morrison, William H.

AU - Nehal, Kishwer S.

AU - Nelson, Kelly C.

AU - Nghiem, Paul

AU - Perlis, Clifford S.

AU - Shaha, Ashok R.

AU - Thorstad, Wade L.

AU - Tuli, Malika

AU - Urist, Marshall M.

AU - Wang, Timothy S.

AU - Werchniak, Andrew E.

AU - Wong, Sandra L.

AU - Zic, John A.

AU - McMillian, Nicole

AU - Hoffman, Karin

AU - Ho, Maria

PY - 2014/6/1

Y1 - 2014/6/1

N2 - Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue tumor characterized by a relatively high risk of local recurrence and low risk of metastasis. The NCCN Guidelines for DFSP provide multidisciplinary recommendations on the management of patients with this rare disease. These NCCN Guidelines Insights highlight the addition of the Principles of Pathology section, which provides recommendations on the pathologic assessment of DFSP. Because DFSP can mimic other lesions, immunohistochemical studies are often required to establish diagnosis. Cytogenetic testing for the characteristic translocation t(17;22)(q22;q13) can also be valuable in the differential diagnosis of DFSP with other histologically similar tumors.

AB - Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue tumor characterized by a relatively high risk of local recurrence and low risk of metastasis. The NCCN Guidelines for DFSP provide multidisciplinary recommendations on the management of patients with this rare disease. These NCCN Guidelines Insights highlight the addition of the Principles of Pathology section, which provides recommendations on the pathologic assessment of DFSP. Because DFSP can mimic other lesions, immunohistochemical studies are often required to establish diagnosis. Cytogenetic testing for the characteristic translocation t(17;22)(q22;q13) can also be valuable in the differential diagnosis of DFSP with other histologically similar tumors.

UR - http://www.scopus.com/inward/record.url?scp=84902437324&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2014.0081

DO - 10.6004/jnccn.2014.0081

M3 - Review article

C2 - 24925197

AN - SCOPUS:84902437324

SN - 1540-1405

VL - 12

SP - 863

EP - 868

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Dermatofibrosarcoma protuberans, version 1.2014

Abstract

Access to Document

Other files and links

Fingerprint

Cite this